Our results strongly implicate CatD in the proteostasis of both Aβ and tau in vivo, suggesting that deficiencies in CatD levels and/or activity might play a causal role in the pathogenesis of AD and potentially other tauopathies. The gene discussed is MAPT; the disease is Alzheimer disease.